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Abstracts / Biol Blood Marrow Transplant 19 (2013) S150eS166 S159similar between the MSD and AD groups (15.1% vs 15.5%,
P ¼ .658; 90.2% vs 82.1%, P ¼ .201; respectively). With an
excellent outcome in MUD HSCT (95.5% 3-year survival),
the survival rate of the matched donor group (MSD+MUD)
collectively was much better than that of the mismatched
group (MMRD+MMUD) (91.6% vs 76.1%, P ¼ .019). In
univariate analysis, conditioning without radiation was the
only risk factor for graft failure (P¼.045). Grades II-IV acute
GVHD (P ¼ .013) and graft failure (p¼0.001) were risk
factors for poor survival. In multivariate analysis, only graft
failure was signiﬁcantly associated with survival proba-
bility (P ¼ .012). Collectively, these data suggest that
conditioning with radiation is important for engraftment
and successful HSCT. MUD HSCTs are highly successful and
may be considered a ﬁrst line therapy in the absence of
MSD.89
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Introduction: Bone marrow transplantation (BMT) is cura-
tive for hemoglobinopathies but its utilization in sickle cell
disease (SCD) is sparse. Though there were 100,000 affected
with SCD in the USA, BMT has been utilized in less than 1000
individuals. As SCD has variable clinical course, confusion
prevails regarding indication, timing of BMT, beneﬁts and
risks for individuals due to morbidity/mortality of the
procedure.
Methods: We used the Pediatric Health Information System
(PHIS), an electronic database of children's hospitals in the
US. Patients under the age of 21 who underwent BMT at one
of the 26 PHIS hospitals from 2000-2011 were analyzed. We
abstracted data on demographics, hospitalizations, BMT and
related complications.
Results: From 2000 to 2011, there were 1365 unique
pediatric patients with SCD were identiﬁed. Among these
228 (17%) children underwent BMT and their demographic
and baseline characteristics are shown in Figure 1A.
Overall, the number of new patients with SCD getting
hospitalized has decreased consistently whereas children
undergoing BMT has increased (Figure 1B). There was
a signiﬁcant decrease in hospitalizations after BMT
compared to pre-BMT state (median hospitalization 2 vs. 4
respectively, n¼173, P  .0001). After BMT, 6% (13/228) of
patients developed stroke, 14% (31/228) had CMV infec-
tion, 9% (21/228) developed invasive fungal infections,
2.2% (5/228) had VOD, and 23% (24/102) developed GVHD.
Seventeen patients (7.4%) died related to BMT with more
deaths occurred when BMT performed at age 11 years
compared to age 210 years (13/108 vs. 4/120 respectively,
P ¼ .029).
Conclusions: We show an increasing trend of BMT utiliza-
tion in children with SCD. In this largest BMT cohort of SCD,
transplant related mortality is very low especially if BMT is
performed before 10 years of age. BMT signiﬁcantly
decreases the overall hospitalizations in these patients.
Studies addressing the barriers of BMT and hydroxyurea
utilization are needed to decrease the health burden in this
chronic disease.Figure 1A. Baseline characteristics of SCD patients underwent BMT.
Figure 1B. Overall trend of new SCD diagnosis and BMT in children and
adoloscents.
